SIRT2 promotes murine melanoma progression through natural killer cell inhibition
Abstract SIRT2, an NAD+-dependent histone deacetylase, has been shown to play a pivotal role in various physiological processes, however, its role in cancer is currently controversial. In recent years, SIRT2 has been described as both a tumor suppressor and oncogene with divergent expression and fun...
Main Authors: | Manchao Zhang, Scarlett Acklin, John Gillenwater, Wuying Du, Mousumi Patra, Hao Yu, Bo Xu, Jianhua Yu, Fen Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-92445-z |
Similar Items
-
Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury
by: Xin Zhao, et al.
Published: (2020-03-01) -
The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01) -
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
by: Robert Csaba Kiss, et al.
Published: (2021-07-01) -
A Blue Light-Inducible CRISPR-Cas9 System for Inhibiting Progression of Melanoma Cells
by: Xia Wu, et al.
Published: (2020-11-01) -
The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis-Mediated Innate Immune Response
by: Weiwei Fu, et al.
Published: (2020-01-01)